Cardiovascular & Renal Drugs PNLE Questions
Introduction
Exactly 35 original PNLE-style practice questions are currently published for Cardiovascular & Renal Drugs. The inventory was last updated August 12, 2026. Use this set to practice safe medication decisions, not to infer a guaranteed number of questions on a future exam.
The canonical scope covers antihypertensive, antianginal, heart-failure, antiarrhythmic, diuretic, and renal medications. Questions in this lens help you connect a drug or class with its purpose, expected response, adverse cue, assessment priority, monitoring need, or next nursing action. Anticoagulants and blood-forming medications belong in Hematologic Drugs.
Tangerine places this topic under NP7: Pharmacology, while the official 2025 Enhanced TOS maps the lens across relevant competencies in the official five-subject PNLE TOS. It is not a separate official test subject, and the TOS does not assign a guaranteed microtopic weight. Exact microtopic distribution varies by exam form.
Key concepts
- Match the medication to the physiologic goal
Recognize: Antihypertensives lower pressure or reduce workload; antianginals improve myocardial oxygen balance; heart-failure and diuretic drugs address workload or excess fluid; antiarrhythmics target rhythm; renal medications may require kidney-based monitoring.
Decide: Name the intended physiologic goal before judging whether an assessment finding is therapeutic or concerning.
Avoid: Treating every cardiovascular drug as interchangeable or choosing an answer from the medication name alone. - Prioritize perfusion after pressure-lowering therapy
Recognize: Hypotension, marked dizziness, weakness, syncope, or new poor perfusion after an antihypertensive or sublingual nitroglycerin dose.
Decide: Protect the patient from injury, assess blood pressure and perfusion, and escalate according to the clinical situation, orders, and local protocol.
Avoid: Repeating a dose or labeling symptoms routine before assessing the patient. - Connect heart-failure findings with fluid and organ status
Recognize: New dyspnea, increasing edema, reduced urine output, or worsening fatigue may signal a change in heart-failure or fluid status.
Decide: Assess respiratory status, perfusion, fluid balance, urine output, renal status, and prescribed monitoring before concluding that treatment is effective.
Avoid: Assuming that any change is a simple expected diuretic effect or waiting for severe deterioration before reporting it. - Link potassium-retaining therapy with renal decline
Recognize: Spironolactone-related hyperkalemia risk becomes more concerning when renal function declines. Weakness, paresthesia, or rhythm changes require prompt attention.
Decide: Review available potassium and renal results, assess the patient, and escalate concerning findings while following the prescribed plan.
Avoid: Assuming urine output alone proves electrolyte safety or independently changing treatment without an order or protocol. - Assess rhythm drugs through stability cues
Recognize: Rhythm, pulse, blood pressure, mental status, chest discomfort, and dyspnea must be interpreted together during antiarrhythmic therapy.
Decide: Determine whether the patient is stable while monitoring the rhythm and escalating signs of impaired perfusion or acute deterioration.
Avoid: Selecting an antiarrhythmic response solely because the heart rate is fast or slow. - Keep medication-domain boundaries clear
Recognize: This page centers on six named groups: antihypertensive, antianginal, heart-failure, antiarrhythmic, diuretic, and renal medications. Anticoagulants and blood-forming medications are assigned to Hematologic Drugs.
Decide: Identify the medication domain first, then apply the relevant monitoring and safety principle.
Avoid: Letting a familiar cardiovascular presentation pull the rationale into an excluded medication category.
What to expect on the PNLE
The 35-question inventory supports question forms that ask for an expected medication effect, an adverse or worsening cue, a priority nursing response, a monitoring concern, or the role of a drug during an urgent cardiovascular situation. Representative scope evidence also supports decisions involving nitroglycerin-related hypotension, heart-failure symptom changes, diuretic safety, spironolactone with renal decline, and antiarrhythmic or arrest medication roles.
The live difficulty distribution is easy 6, medium 24, and hard 5. The live Bloom distribution is remembering 11, understanding 5, applying 14, analyzing 3, and evaluating 2. This profile supports strong retrieval of drug purposes and safety facts, with particular practice in applying a clinical cue to the correct nursing action. Exact topic distribution varies by exam form.
- Remembering: Retrieve medication purposes, class associations, and key monitoring concerns.
- Understanding: Explain why a finding reflects therapeutic response, adverse effect, or worsening disease.
- Applying: Use blood pressure, rhythm, fluid, renal, and electrolyte cues to select the safest action.
- Analyzing and evaluating: Prioritize competing findings, distinguish stable from unstable presentations, and judge which option best protects perfusion and medication safety.
Study tips
- Start with diagnostic practice. Answer a short mixed set drawn from the 35 published questions without opening notes. Mark whether each miss came from drug purpose, assessment, adverse effect, prioritization, or scope confusion.
- Use focused retrieval by drug group. For each class, recall the main physiologic goal, the first assessment, the important monitoring concern, the dangerous cue, and the nursing action. Say the reasoning aloud before checking the answer.
- Make a comparison grid. Draw five columns and complete one row for each class: Class | Main goal | First assessment | Danger cue | Nursing response.Example diagram to complete:
Antihypertensive | ____ | ____ | ____ | ____
Antianginal | ____ | ____ | ____ | ____
Heart-failure or diuretic | ____ | ____ | ____ | ____
Antiarrhythmic | ____ | ____ | ____ | ____
Renal medication | ____ | ____ | ____ | ____ - Review the rationale and the error. For every missed or guessed item, write the clinical cue, the safety risk, and the action that follows. Record why each distractor is less safe rather than copying only the correct letter.
- Retry with spacing, then mix. Reattempt missed concepts after a gap, using new wording and a different drug group when possible. Once focused retrieval is reliable, complete mixed timed practice that combines all six groups and requires both recall and clinical decision-making.
Common mistakes to avoid
- Calling post-dose dizziness automatically expected. A learner may remember that pressure-lowering drugs can cause dizziness and stop reasoning. The correcting cue is the patient’s blood pressure, perfusion, severity of symptoms, and injury risk; assess first and escalate when findings are concerning.
- Judging heart-failure therapy from one symptom. Improved urine output does not by itself establish safe or effective treatment. Compare respiratory status, edema, fluid balance, urine output, perfusion, renal status, and ordered monitoring.
- Missing the spironolactone and renal-decline connection. Focusing only on fluid removal can hide potassium risk. Renal decline increases concern for hyperkalemia, so review relevant results and assess for weakness or rhythm changes.
- Choosing an antiarrhythmic by rate alone. A fast or slow pulse is incomplete information. Rhythm, blood pressure, mental status, chest discomfort, dyspnea, and perfusion determine urgency and the safest next action.
- Mixing medication domains. Cardiovascular symptoms can appear in questions about anticoagulants or blood-forming medications, but those belong to Hematologic Drugs. Identify the drug category before applying a rationale so the monitoring principle matches the scope.
Try a question
A real Cardiovascular & Renal Drugs question from our bank. Give it a shot.
A patient receiving digoxin for heart failure begins to complain about unusual visual disturbances and a lack of appetite. What should the nurse suspect as the possible cause?
Digoxin is a cardiac glycoside widely used in the treatment of heart failure and certain arrhythmias. Its therapeutic window is narrow, meaning there is a fine line between effective and toxic doses. Patients on digoxin must be closely monitored for signs of toxicity, especially since several factors—including drug interactions and electrolyte disturbances—can precipitate adverse effects even at normal blood levels.
Why C is Correct: Visual disturbances (such as blurred vision, yellow-green halos, or photophobia) and gastrointestinal symptoms (such as anorexia, nausea, or vomiting) are classic early signs of digoxin toxicity. These symptoms can precede more severe manifestations such as life-threatening cardiac arrhythmias. Therefore, any report of unusual visual symptoms and loss of appetite in a patient taking digoxin should immediately prompt the nurse to suspect digoxin toxicity and notify the healthcare provider. Acting quickly can prevent progression to more serious complications.
| Common Early Signs of Digoxin Toxicity |
|---|
| Gastrointestinal disturbances: anorexia, nausea, vomiting |
| Visual changes: blurred vision, yellow-green halos |
| Fatigue, weakness |
Why the Other Options Are Incorrect:
| Option | Why It's Incorrect |
|---|---|
| A | Anxiety can cause vague symptoms like appetite changes, but it does not typically produce visual disturbances like those described. Visual changes are more specific to digoxin toxicity. |
| B | Low potassium (hypokalemia) increases sensitivity to digoxin and the risk of toxicity, but the symptoms described are not directly due to hypokalemia itself. While hypokalemia is a major risk factor, the symptoms presented point towards toxicity, not just low potassium. |
| D | Decreased cardiac output may cause fatigue or confusion, but does not characteristically lead to visual disturbances and anorexia. These specific symptoms are more closely tied to digoxin side effects. |
Nursing Concepts and Clinical Reasoning
- Nurses must understand the significance of early warning signs of drug toxicity and how to prioritize patient safety. Recognizing subtle symptoms allows for prompt intervention and prevents adverse outcomes.
- Monitoring for digoxin toxicity is a standard nursing responsibility when caring for patients on this medication. This includes regular assessment, educating the patient on what to watch for, and ensuring appropriate laboratory monitoring (serum digoxin and electrolyte levels).
Clinical Pearls:
- "Seeing green or yellow halos" is a classic memory aid for digoxin toxicity.
- Hypokalemia makes the heart more susceptible to digoxin's toxic effects, so potassium levels should be monitored closely.
- Always check apical pulse before administering digoxin, and withhold the drug if the pulse is below parameters set by facility policy or the provider.
Prompt recognition and intervention are critical components of safe medication administration, as highlighted in key nursing texts and examination standards.
- Silvestri, L. A. (2017). Saunders Comprehensive Review for the NCLEX-RN Examination (7th ed.). Elsevier.
More Cardiovascular & Renal Drugs questions
28 questions available. Sign up to practice all of them.
A hospitalized patient with suspected acute coronary syndrome receives one prescribed sublingual nitroglycerin dose. Five minutes later, chest pain persists, the patient is dizzy, and blood pressure is 86/54 mmHg. What should the nurse do next?
Pulseless VT persists after two shocks. CPR has resumed, IV access is ready, and no drug has been given. Which sequence best follows the shockable-arrest algorithm if the rhythm remains shockable?
Ascites improves on spironolactone, but potassium rises from 4.7 to 5.8 mmol/L and eGFR falls. Which response best balances benefit and harm?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.